HALOZYME REPORTS FIRST QUARTER 2026 RESULTS AND REITERATES 2026 FINANCIAL GUIDANCE
Go back to HALOZYME REPORTS FIRST QUARTER 2026 RESULTS AND REITERATES 2026 FINANCIAL GUIDANCE| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 68.99 +0.44 (0.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.55 | 52 Week High | $18.39 | |||
| Open | $69.34 | 52 Week Low | $6.96 | |||
| Day High | $69.81 | P/E | N/A | |||
| Day Low | $68.27 | EPS | $-0.58 | |||
| Volume | 1,050,071 | |||||
